ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

IBIO iBio Inc

1.9519
-0.0781 (-3.85%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
iBio Inc IBIO AMEX 普通株式
  前日比 前日比 % 現在値 時刻
-0.0781 -3.85% 1.9519 08:27:18
始値 安値 高値 終値 前日終値
2.03 1.95 2.15 1.99 2.03
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2720:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
2024/3/2708:35GLOBEiBio Announces $15.0 Million Private Placement
2024/2/2621:59EDGAR2Form 8-K - Current report
2024/2/2621:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
2024/2/2206:55EDGAR2Form 8-K - Current report
2024/1/2006:36EDGAR2Form 8-K - Current report
2024/1/1622:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
2024/1/1103:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/0906:30EDGAR2Form 8-K - Current report
2024/1/0422:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/2621:44EDGAR2Form 8-K - Current report
2023/12/2621:15GLOBEiBio Amends and Extends Maturity of Credit Agreement
2023/12/0906:17EDGAR2Form 8-K - Current report
2023/12/0623:13EDGAR2Form 8-K - Current report
2023/12/0622:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/0522:00GLOBEiBio, Inc. Announces Pricing of $4.5 Million Public Offering
2023/12/0514:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/3022:55EDGAR2Form S-1/A - General form for registration of securities..
2023/11/2822:36EDGAR2Form 8-K - Current report
2023/11/2807:20GLOBEiBio Announces Reverse Stock Split
2023/11/0405:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0121:24GLOBEiBio Further Expands Tech Stack with ShieldTx™; Enhances..
2023/10/2805:29EDGAR2Form S-1 - General form for registration of securities under..
2023/10/2621:20EDGAR2Form DEF 14A - Other definitive proxy statements
2023/10/1705:59EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/10/1021:56EDGAR2Form 8-K - Current report
2023/10/1021:00GLOBEiBio to Highlight Technology for Advancing Discovery of..
2023/10/0605:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0405:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0305:34EDGAR2Form 8-K - Current report
2023/10/0219:45GLOBEiBio Explains Recent Filing of Registration Statement
2023/9/3006:28EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/9/2805:31EDGAR2Form 8-K - Current report
2023/9/2805:19GLOBEiBio Announces Filing of 2023 Annual Report on SEC Form 10-K
2023/9/2805:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/9/2205:05GLOBEiBio Announces Amendment to Credit Agreement with Woodforest
2023/9/2121:00EDGAR2Form 8-K - Current report
2023/8/3105:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2505:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2505:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1505:15GLOBEiBio Reports Triple Milestone: In Vivo Proof-of-Concept for..
2023/8/1504:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/0805:01EDGAR2Form 8-K - Current report
2023/8/0722:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/0505:47EDGAR2Form 8-K - Current report
2023/7/2905:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1405:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1021:29EDGAR2Form 8-K - Current report
2023/6/2721:00GLOBEiBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO..
2023/6/1305:15GLOBEiBio Forges Research Collaboration with the National..

最近閲覧した銘柄

Delayed Upgrade Clock